Hepatocellular Carcinoma News and Research

RSS
New book examines all aspects of HBV and HDV infections

New book examines all aspects of HBV and HDV infections

Scientists reveal new combination method that efficiently destroys cancer cells

Scientists reveal new combination method that efficiently destroys cancer cells

Certain ARID1a mutations sensitize some tumors to PARP inhibitor drugs

Certain ARID1a mutations sensitize some tumors to PARP inhibitor drugs

CASI files application with CFDA to conduct ENMD-2076 Phase 2 trial in fibrolamellar carcinoma patients

CASI files application with CFDA to conduct ENMD-2076 Phase 2 trial in fibrolamellar carcinoma patients

Exalenz Bioscience initiates BreathID clinical study to detect primary liver cancer

Exalenz Bioscience initiates BreathID clinical study to detect primary liver cancer

Game changing, breakthrough early cancer detection technology presented at ASCO 2015

Game changing, breakthrough early cancer detection technology presented at ASCO 2015

Clinical utility of Caris Molecular Intelligence in five studies to be presented at ASCO 2015

Clinical utility of Caris Molecular Intelligence in five studies to be presented at ASCO 2015

AACR, Bayer partner to expand Basic Cancer Research Fellowship Program for 2015

AACR, Bayer partner to expand Basic Cancer Research Fellowship Program for 2015

CLDF collaborates with Walgreens to offer free rapid HCV testing

CLDF collaborates with Walgreens to offer free rapid HCV testing

Researchers uncover mechanism behind common mutation that helps cancer cells replicate limitlessly

Researchers uncover mechanism behind common mutation that helps cancer cells replicate limitlessly

Alnylam files clinical trial application for alpha-1 liver disease, presents data at DDW

Alnylam files clinical trial application for alpha-1 liver disease, presents data at DDW

MD Anderson researchers find significant clinical variations among liver cancer patients

MD Anderson researchers find significant clinical variations among liver cancer patients

Simple blood test could help predict effectiveness of interferon-based therapy in HCV-infected patients

Simple blood test could help predict effectiveness of interferon-based therapy in HCV-infected patients

Overview of Blueprint Medicines' kinase drug discovery strategy published in JCI

Overview of Blueprint Medicines' kinase drug discovery strategy published in JCI

Can-Fite receives EMA clearance to begin CF102 Phase II trial for treatment of HCC patients in Europe

Can-Fite receives EMA clearance to begin CF102 Phase II trial for treatment of HCC patients in Europe

Exalenz Bioscience investigates clinical utility of BreathID test to diagnose NASH

Exalenz Bioscience investigates clinical utility of BreathID test to diagnose NASH

Will new hepatitis C treatments strain payers’ budgets? An interview with Dr Chhatwal

Will new hepatitis C treatments strain payers’ budgets? An interview with Dr Chhatwal

Occurrence of advanced liver fibrosis similar for patients with HCV infection

Occurrence of advanced liver fibrosis similar for patients with HCV infection

Therapeutic candidate BLU-554 has significant anti-tumor activity in HCC models

Therapeutic candidate BLU-554 has significant anti-tumor activity in HCC models

Study identifies BLU-554 as potential treatment option for HCC patients

Study identifies BLU-554 as potential treatment option for HCC patients

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.